Background: In the CABANA trial (Catheter Ablation vs Antiarrhythmic Drug Therapy for
Atrial Fibrillation), catheter ablation did not significantly reduce the primary end point of …

Introduction: There is emerging evidence for clinical superiority of catheter ablation over rate
and rhythm control strategies in paroxysmal atrial fibrillation (PAF). The objective of this …

Background—Patients with atrial fibrillation (AF) face significant risks of stroke and heart
failure. The objective of this study was to determine whether AF ablation reduces the long …

Catheter Ablation in AF Patients, Including Age 65+, Reduces Utilization. Aim: The aim was
to estimate the impact of catheter ablation on short‐and long‐term healthcare utilization and …

Abstract The Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation
(CABANA, NCT00911508)(1) trial is testing the hypothesis that the treatment strategy of …

Background—Radiofrequency catheter ablation (RFA) has emerged as an important
treatment strategy for atrial fibrillation (AF). The potential cost-effectiveness of RFA for AF …

Objectives: We sought to compare the cost-effectiveness of left atrial catheter ablation
(LACA), amiodarone, and rate control therapy in the management of atrial fibrillation (AF) …

Importance Catheter ablation is effective in restoring sinus rhythm in atrial fibrillation (AF),
but its effects on long-term mortality and stroke risk are uncertain. Objective To determine …

Abstract Aims The Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation
(CABANA) trial aimed to assess the impact of ablation on morbidity and mortality. This …

Background: Observational data suggest that catheter ablation may be safe and effective to
treat younger and older patients with atrial fibrillation. No large, randomized trial has …